AI camera test for wet AMD detection
Part of Eyes & vision clinical trials.
This study tests a new AI-powered camera that takes special pictures of the back of the eye to find signs of wet age-related macular degeneration (AMD) more easily. It compares images from people with wet AMD and healthy volunteers to see if the AI can spot the disease early.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 40 years old or older.
- You have been diagnosed with wet (neovascular) age-related macular degeneration, or you are a healthy volunteer without any AMD.
- You have not had any eye surgery (like cataract or retina surgery) in the past 3 months.
- You do not have other serious eye diseases, like diabetic retinopathy or severe nearsightedness (myopia over -10).
- You can keep your eyes still and focus on a target during the imaging test.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an AI system designed to catch early signs of late age-related macular degeneration (AMD) before it's diagnosed. It's for people who haven't yet been diagnosed with AMD or treated for retinal disease.
This trial uses an AI system to test if it can find early signs of diabetic eye disease (diabetic retinopathy) in people with diabetes. If you have diabetes but no known eye problems, the AI might help catch issues early.
This study uses artificial intelligence to track changes in the eyes of people with early or intermediate age-related macular degeneration (AMD). It aims to better understand how the disease progresses and may help doctors personalize care.
This trial uses artificial intelligence to track changes in the eyes of people with advanced age-related macular degeneration (AMD) that has caused a specific type of damage (atrophy) in the retina. The goal is to see if AI can help detect when the disease gets worse, so doctors can personalize monitoring for each patient.
This study tests new ways to measure vision and take detailed eye images in people with age-related macular degeneration (AMD), a common eye condition affecting central vision. The goal is to develop better tools for future AMD treatment trials.
This study tests a web-based eye-tracking tool to monitor vision impairment in people with wet age-related macular degeneration (AMD). You would use your computer at home, which could help reduce the need for frequent clinic visits.
Hear when a new Age-Related (Dry) Macular Degeneration trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.